DoseAware

For interventional radiologists, Philips will introduce DoseAware, the latest addition to Philips' DoseWise portfolio of solutions to help track X-ray exposure of patients and staff. DoseAware delivers real-time visualization, display and tracking of clinical staff X-ray dose to help healthcare professionals performing potentially lengthy interventional procedures manage their radiation exposure on the spot.


EasyDiagnost Eleva

A single fluoroscopy room is not cost-effective in today's environment with a shift of exams to other modalities. The combination of Philips' high-end digital vertical stand (or digital in-table detector) and the EasyDiagnost Eleva with ceiling suspension manages both high-quality digital radiography as well as fluoroscopy (DRF) applications, enabling users to perform gastro-intestinal work, as well as chest and skeletal exams, in just one room.

In addition, the DRF design consists of various single features to help enable lower X-ray doses to be delivered, including pediatric fluoroscopy settings, Grid Controlled Fluoroscopy and dose measurement. This is especially relevant in the pediatric setting. The Eleva is easy to operate, fast and offers the ability to customize protocols and techniques for individual physician preferences. Based on open standards, the EasyDiagnost Eleva can seamlessly integrate into any hospital network.

GEMINI TF PET/CT

Showcasing Philips' newest innovation in oncology care, the Philips GEMINI TF PET/CT streamlines the processes involved in staging, planning, therapy and follow-up in oncology care. With Generation 3 Time-of-Flight technology, the GEMINI TF system is the company's fastest ever PET scanner, capturing data in less than 500 picoseconds, without compromising image quality or attention to dose radiation efficiency.

Philips GEMINI TF is seeing increased traction for oncology diagnosis and follow-up. The U.S. Centers for Medicare and Medicaid Services (CMS) final decision expands coverage for Medicare patients for 11 cancer types and adds new coverage for initial treatment in seven other cancer indications. FDG-PET exams, such as those performed on the GEMINI TF, can be performed as part of the initial treatment strategy and to further guide subsequent treatment strategies. Philips GEMINI TF family will now play an even larger role in women's care due to the recent CMS decision to expand Medicare coverage for the reimbursement of exams for the initial staging of patients with biopsy-proven cervical cancer.

More HCB News